Innoviva (NASDAQ: INVA) reported Q1 EPS of $0.46, $0.28 better than the analyst estimate of $0.18. Revenue for the quarter came in at $77.5 million versus the consensus estimate of $73.31 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.